by Bayerisches-ZKF-30-03-20 | Jun 22, 2020 | News
The 7th Immunotherapy of Cancer Conference (ITOC7) to be held in Munich, Germany from October 3 – 5, 2020 is a European meeting providing a global platform for translational research in the field of immuno-oncology as well as a forum for discussion of early...
by Bayerisches-ZKF-30-03-20 | Jun 22, 2020 | News
The ASPO symposia were initiated in 2004 at the LMU Klinikum München. Since 2020, both University Hospitals have been bundling their oncological training events under the umbrella of the CCC Munich. The new training series ASPO has developed from this: Experts from...
by Bayerisches-ZKF-30-03-20 | Jun 22, 2020 | News
The ASPO symposia were initiated in 2004 at the LMU Klinikum München. Since 2020, both University Hospitals have been bundling their oncological training events under the umbrella of the CCC Munich. The new training series ASPO has developed from this: Experts from...
by Bayerisches-ZKF-30-03-20 | Jun 22, 2020 | Forschung, News
Under the coordination of the LMU Clinic, the perCELLUM (Personalized Cellular Therapies Munich) project was one of 16 finalists to qualify for possible funding. Sixteen of the 137 applicants were invited to apply and 8 will be funded by the BMBF with 50-60 million...
by Bayerisches-ZKF-30-03-20 | Jun 22, 2020 | News
Information event for patients, relatives and interested parties. New therapeutic options for multiple myelomaProf. Dr. med. Hermann EinseleWhat is the use of bone marrow examination at MM for the treatment designProf. Dr. med. Martin KortümThe CAR tsunami hits...
by Bayerisches-ZKF-30-03-20 | Jun 22, 2020 | Forschung, News, Working groups
Based on the existing expertise in Bavaria, immuno-oncology is to be the first joint research focus of the BZKF. The aim is to prevent or detect significantly more cancers earlier and to be able to cure more cancers through new personalised and immunotherapeutic...
Recent Comments